PDF question factsheets

directory textify_t

10-hypertension-anti hypertensive agent.pdf

10-hypertension-anti hypertensive agents.pdf

100-venous thrombosis-fibrinolysis.pdf

101-venous thrombosis-antithrombotics.pdf

102-pulmonary embolism-antithrombotics.pdf

103-venous thrombosis-antithrombotics.pdf

104-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf

105-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf

106-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf

107-prevention of sudden death-resynchronization (CRT) - defibrillators (ICD).pdf

108-prevention of sudden death-resynchronization (CRT) - defibrillators (ICD).pdf

109-prevention of sudden death-resynchronization (CRT) - defibrillators (ICD).pdf

11-cardiovascular prevention-cholesterol lowering intervention.pdf

110-pulmonary embolism-fibrinolysis.pdf

112-atrial fibrillation-rythm control.pdf

113-atrial fibrillation-antiarrythmic drugs.pdf

117-heart failure-phosphodiesterase III inhibitors .pdf

118-stable angina-HR-slowing agents.pdf

119-heart failure-beta-blockers.pdf

12-cardiovascular prevention-cholesterol lowering intervention.pdf

120-cardiovascular prevention-antithrombotics.pdf

121-cardiovascular prevention-omega-3 fatty acids .pdf

122-venous thrombosis-caval filter.pdf

123-cardiovascular prevention-omega-3 fatty acids .pdf

124-cardiovascular prevention-omega-3 fatty acids .pdf

125-hypertension-angiotensin-receptor blockers.pdf

126-cardiovascular prevention-cholesterol lowering intervention.pdf

127-cardiovascular prevention-plasma homocysteine lowering intervention.pdf

129-acute myocardial infarction-myocardial revascularization.pdf

13-hypertension-anti hypertensive agent.pdf

13-hypertension-anti hypertensive agents.pdf

130-acute myocardial infarction-antiarrythmic drugs.pdf

131-cardiovascular prevention-antioxydants.pdf

132-cardiovascular prevention-antithrombotics.pdf

133-acute myocardial infarction-myocardial revascularization.pdf

134-acute myocardial infarction-Late revascularisation.pdf

135-acute myocardial infarction-myocardial revascularization.pdf

136-familial hypercholesterolemia -cholesterol lowering intervention.pdf

137-cardiovascular prevention-cholesterol lowering intervention.pdf

139-progression of atherosclerosis-cholesterol lowering intervention.pdf

14-hypertension-anti hypertensive agent.pdf

14-hypertension-anti hypertensive agents.pdf

140-progression of atherosclerosis-cholesterol lowering intervention.pdf

141-acute myocardial infarction-calcium channel blockers.pdf

142-acute myocardial infarction-calcium channel blockers.pdf

143-acute myocardial infarction-calcium channel blockers.pdf

144-acute myocardial infarction-nitrates.pdf

145-acute myocardial infarction-angiotensin-Converting Enzyme Inhibitors.pdf

146-acute myocardial infarction-angiotensin-Converting Enzyme Inhibitors.pdf

147-acute myocardial infarction-angiotensin-Converting Enzyme Inhibitors.pdf

148-percutaneous coronary intervention-statin.pdf

148-percutaneous coronary intervention-statins.pdf

149-venous thrombosis-antithrombotics.pdf

15-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf

150-DVT prophylaxis-antithrombotics.pdf

151-stent-antithrombotics.pdf

152-percutaneous coronary intervention-antithrombotics.pdf

153-post stroke-cholesterol lowering intervention.pdf

154-cardiovascular prevention-cholesterol lowering intervention.pdf

155-cardiovascular prevention-cholesterol lowering intervention.pdf

156-abdominal aortic aneurysm-agents to slow down human AAA-expansion.pdf

157-patients at high risk for cardiovascular events-inhibition of the renin-angiotensin system (ACEI or ARB).pdf

158-DVT prophylaxis-graduated compression stockings.pdf

160-percutaneous coronary intervention-pre treatment for PCI.pdf

161-atrioventricular block or sick sinus syndrome-pacemaker.pdf

162-acute myocardial infarction-cholesterol lowering intervention.pdf

163-carotid stenosis-endarterectomy.pdf

164-carotid stenosis-endovascular treatment.pdf

165-acute coronary syndrome-myocardial revascularization.pdf

167-acute coronary syndrome-anticoagulant.pdf

168-acute coronary syndrome-anticoagulant.pdf

169-acute coronary syndrome-antiplatelets drug.pdf

170-acute coronary syndrome-antiplatelets drug.pdf

171-acute coronary syndrome-heparin (UFH or LMWH).pdf

172-acute myocardial infarction-anticoagulant.pdf

173-post myocardial infarction-anticoagulant.pdf

175-patients at high risk for cardiovascular events-angiotensin-receptor blockers.pdf

176-heart failure-cholesterol lowering intervention.pdf

177-post myocardial infarction-primary prevention of sudden death.pdf

178-prevention of sudden death-antiarrythmic drugs.pdf

179-prevention of sudden death-antiarrythmic drugs.pdf

180-prevention of sudden death-ICD .pdf

181-prevention of sudden death-ICD .pdf

182-cardiac arrest-antiarrythmic drugs.pdf

183-prevention of sudden death-ICD .pdf

184-DVT prophylaxis-anticoagulant.pdf

185-DVT prophylaxis-direct antithrombins.pdf

186-DVT prophylaxis-antiplatelets drug.pdf

187-DVT prophylaxis-direct factor Xa inhibitors.pdf

188-DVT prophylaxis-pentasaccharide.pdf

189-DVT prophylaxis-heparin (UFH or LMWH).pdf

19-hypertension-anti hypertensive agent.pdf

19-hypertension-anti hypertensive agents.pdf

190-DVT prophylaxis-LMWH.pdf

191-DVT prophylaxis-UFH.pdf

192-DVT prophylaxis-UFH.pdf

193-DVT prophylaxis-UFH.pdf

194-DVT prophylaxis-UFH.pdf

195-DVT prophylaxis-heparin (UFH or LMWH).pdf

196-DVT prophylaxis-LMWH.pdf

197-DVT prophylaxis-heparin (UFH or LMWH).pdf

198-DVT prophylaxis-LMWH.pdf

199-DVT prophylaxis-heparin (UFH or LMWH).pdf

20-hypertension-anti hypertensive agent.pdf

20-hypertension-anti hypertensive agents.pdf

200-DVT prophylaxis-LMWH.pdf

201-DVT prophylaxis-heparin (UFH or LMWH).pdf

202-DVT prophylaxis-LMWH.pdf

203-venous thrombosis-LMWH.pdf

204-venous thrombosis-heparin (UFH or LMWH).pdf

205-venous thrombosis-UFH.pdf

206-coronary artery disease-Drug eluting stent.pdf

207-coronary artery disease-Drug eluting stent.pdf

208-coronary artery disease-Drug eluting stent.pdf

209-coronary artery disease-Drug eluting stent.pdf

21-acute coronary syndrome-cholesterol lowering intervention.pdf

210-coronary artery disease-Drug eluting stent.pdf

211-coronary artery disease-Drug eluting stent.pdf

212-coronary artery disease-Drug eluting stent.pdf

213-DVT prophylaxis-pentasaccharide.pdf

214-coronary artery disease-Drug eluting stent.pdf

215-coronary artery disease-Drug eluting stent.pdf

216-coronary artery disease-Drug eluting stent.pdf

217-coronary artery disease-Drug eluting stent.pdf

218-superficial thrombophlebitis-antithrombotics.pdf

22-acute coronary syndrome-myocardial revascularization.pdf

220-cardiovascular prevention-antiplatelets drug.pdf

221-diabetes type 2-antiplatelets drug.pdf

222-acute coronary syndrome-calcium channel blockers.pdf

223-acute coronary syndrome-fibrinolysis.pdf

224-acute coronary syndrome-nitrates.pdf

225-CABG surgery-antiplatelets drug.pdf

226-cardiovascular prevention-antiplatelets drug.pdf

227-cardiovascular prevention-antithrombotics.pdf

228-diabetes type 2-antithrombotics.pdf

229-peripheral vascular diseases-antioxydants.pdf

230-peripheral vascular diseases-antioxydants.pdf

231-diabetes type 2-antioxydants.pdf

232-cardiovascular prevention-antioxydants.pdf

233-heart failure-angiotensin-receptor blockers.pdf

234-heart failure-inhibition of the renin-angiotensin system (ACEI or ARB).pdf

235-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf

236-heart failure-diuretics.pdf

237-heart failure with preserved LVEF -All mechanism.pdf

238-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf

239-cardiac arrest-fibrinolysis.pdf

24-acute coronary syndrome-antithrombotics.pdf

240-diabetes type 2-intensive glycemic control .pdf

241-cardiovascular prevention-cholesterol lowering intervention.pdf

242-heart failure-vasopressin antagonist.pdf

243-heart failure-vasopeptidase inhibitor.pdf

246-acute myocardial infarction-PCI.pdf

248-acute myocardial infarction-myocardial revascularization.pdf

249-acute myocardial infarction-myocardial revascularization.pdf

25-stable angina-myocardial revascularization.pdf

250-acute myocardial infarction-glucose insulin potassium.pdf

251-post myocardial infarction-antiarrythmic drugs.pdf

252-post myocardial infarction-calcium channel blockers.pdf

253-acute myocardial infarction-angiotensin-receptor blockers.pdf

254-acute myocardial infarction-myocardial revascularization.pdf

255-acute myocardial infarction-PCI.pdf

256-acute myocardial infarction-myocardial revascularization.pdf

257-acute myocardial infarction-PCI.pdf

259-acute myocardial infarction-PCI.pdf

26-coronary artery disease-myocardial revascularization.pdf

260-acute myocardial infarction-fibrinolysis.pdf

261-acute myocardial infarction-fibrinolysis.pdf

262-stable angina-HR-slowing agents.pdf

263-stable angina-anti-anginal drugs.pdf

264-acute coronary syndrome-anti-anginal drugs.pdf

265-obesity and overweight-All mechanism.pdf

267-diabetes type 2-intensive glycemic control .pdf

268-diabetes type 2-intensive glycemic control .pdf

269-atrial fibrillation-antiarrythmic drugs.pdf

27-stable angina-myocardial revascularization.pdf

270-cardiac arrest-vasopressin.pdf

271-heart failure-BNP guided management .pdf

272-carotid stenosis-endarterectomy.pdf

273-atrial fibrillation-antiarrythmic drugs.pdf

274-coronary artery disease-transmyocardial revacularization.pdf

275-cardiovascular prevention-antiplatelets drug.pdf

276-cardiovascular prevention-antiplatelets drug.pdf

277-post myocardial infarction-antiplatelets drug.pdf

278-peripheral vascular diseases-antiplatelets drug.pdf

28-stable angina-myocardial revascularization.pdf

280-carotid stenosis-endovascular treatment.pdf

281-hypertension-anti hypertensive agent.pdf

281-hypertension-anti hypertensive agents.pdf

282-cardiovascular prevention-lifestyle intervention.pdf

283-post myocardial infarction-omega-3 fatty acids .pdf

284-cardiovascular prevention-cholesterol lowering intervention.pdf

285-diabetes type 2-screening for CAD .pdf

287-heart failure-relaxine.pdf

288-restenosis after PCI-Intravascular Brachytherapy.pdf

289-DVT prophylaxis-antithrombotics.pdf

29-stable angina-myocardial revascularization.pdf

290-heart failure-surgery.pdf

291-percutaneous coronary intervention-antithrombotics.pdf

292-acute myocardial infarction-cell-based therapies .pdf

293-heart failure-vasopressin antagonist.pdf

294-heart failure-new drug under development.pdf

295-acute myocardial infarction-new drug under development.pdf

296-CABG surgery-preconditioning .pdf

298-acute myocardial infarction-new drug under development.pdf

299-coronary artery disease-cell-based therapies .pdf

30-coronary artery disease-myocardial revascularization.pdf

300-coronary artery disease-cell-based therapies .pdf

301-heart failure-increasing hemoglobin concentration .pdf

302-percutaneous coronary intervention-anti inflammatory drugs.pdf

303-acute myocardial infarction-complement inhibition.pdf

304-acute myocardial infarction-complement inhibition.pdf

305-cardiovascular prevention-omega-3 fatty acids .pdf

306-cardiac arrest-omega-3 fatty acids .pdf

307-restenosis after PCI-new drug under development.pdf

308-acute myocardial infarction-heparin (UFH or LMWH).pdf

309-hypertension-renin inhibitor .pdf

31-coronary artery disease-myocardial revascularization.pdf

310-hypertension-renin inhibitor .pdf

311-heart failure-renin inhibitor .pdf

312-heart failure-anti inflammatory drugs.pdf

313-acute myocardial infarction-cell-based therapies .pdf

314-heart failure-diuretics.pdf

315-CABG surgery-off-pump CABG.pdf

316-acute myocardial infarction-PCI.pdf

317-acute myocardial infarction-myocardial revascularization.pdf

318-percutaneous coronary intervention-restenosis prevention.pdf

319-heart failure-renin inhibitor .pdf

32-coronary artery disease-myocardial revascularization.pdf

320-atrial fibrillation-catheter ablation .pdf

321-diabetes type 2-insulin sensitizers - glitazones.pdf

322-cardiovascular prevention-antiplatelets drug.pdf

323-stent-antiplatelets drug.pdf

324-stent-antithrombotics.pdf

325-stent-antithrombotics.pdf

326-cardiovascular prevention-niacin.pdf

328-atrial fibrillation-prevention.pdf

33-stable angina-antithrombotics.pdf

330-heart failure-Exercise Therapy.pdf

331-atrial fibrillation-prevention.pdf

335-peripheral vascular diseases-cell-based therapies .pdf

336-hypertension-intensive blood pressure control.pdf

337-atrial fibrillation-embolic protection.pdf

338-CABG surgery-vein grafts pretreatment.pdf

339-cardiovascular prevention-ACAT inhibition.pdf

34-stable angina-antibiotics.pdf

340-cardiovascular prevention-CEPT inhibition.pdf

341-diabetes type 2-prevention.pdf

342-impaired fasting glucose -prevention.pdf

343-hypertension-intensive blood pressure control.pdf

344-hypertension-intensive blood pressure control.pdf

345-acute coronary syndrome-direct factor Xa inhibitors.pdf

346-acute coronary syndrome-antiplatelets drug.pdf

347-acute coronary syndrome-antithrombotics.pdf

348-acute coronary syndrome-antithrombotics.pdf

349-heart failure-resynchronization (CRT) - defibrillators (ICD).pdf

35-acute coronary syndrome-antithrombotics.pdf

350-acute myocardial infarction-thrombectomy.pdf

351-coronary artery disease-anti-anginal drugs.pdf

352-acute myocardial infarction-percutaneous left ventricular assist devices.pdf

353-acute myocardial infarction-ICD .pdf

354-percutaneous coronary intervention-radial access.pdf

355-percutaneous coronary intervention-thrombectomy.pdf

356-abdominal aortic aneurysm-endovascular treatment.pdf

357-percutaneous coronary intervention-proton-pump inhibitors.pdf

358-stable angina-spinal cord stimulation.pdf

359-coronary artery disease-anti-anginal drugs.pdf

36-acute myocardial infarction-antithrombotics.pdf

360-percutaneous coronary intervention-anti-anginal drugs.pdf

362-diabetes type 2-antiplatelets drug.pdf

363-post acute coronary syndromes -antithrombotics.pdf

364-post myocardial infarction-antithrombotics.pdf

365-heart failure-percutaneous left ventricular assist devices.pdf

366-cardiac arrest-Public Access Defibrillation .pdf

367-throracic aortic aneuvrism-endovascular treatment.pdf

368-atrial fibrillation-direct antithrombins.pdf

369-DVT prophylaxis-direct antithrombins.pdf

37-DVT prophylaxis-antithrombotics.pdf

370-venous thrombosis-direct antithrombins.pdf

371-DVT prophylaxis-direct factor Xa inhibitors.pdf

372-venous thrombosis-direct factor Xa inhibitors.pdf

373-atrial fibrillation-direct factor Xa inhibitors.pdf

374-hypertension-anti hypertensive agent.pdf

374-hypertension-anti hypertensive agents.pdf

376-diabetes type 2-insulin sensitizers - glitazones.pdf

377-diabetes type 2-insulin sensitizer.pdf

378-diabetes type 2-insulin sensitizer.pdf

379-diabetes type 2-alpha-glucosidase inhibitors .pdf

38-DVT prophylaxis-antithrombotics.pdf

380-DVT prophylaxis-pentasaccharide.pdf

381-diabetes type 2-insulin secretagogues peptides (incretins).pdf

382-ventricular tachycardia in patients with structural heart disease -catheter ablation of ventricular tachycardia .pdf

383-patients with implantable cardioverter defibrillators -omega-3 fatty acids .pdf

384-patients with implantable cardioverter defibrillators -catheter ablation .pdf

385-aortic stenosis-cholesterol lowering intervention.pdf

386-DVT prophylaxis-antithrombotics.pdf

387-acute coronary syndrome-antithrombotics.pdf

388-percutaneous coronary intervention-anticoagulant.pdf

389-percutaneous coronary intervention-antiplatelets drug.pdf

39-DVT prophylaxis-antithrombotics.pdf

390-acute myocardial infarction-antiplatelets drug.pdf

391-atrial fibrillation-direct oral anticoagulant (DAO).pdf

392-atrial fibrillation-antithrombotics.pdf

393-DVT prophylaxis-direct oral anticoagulant (DAO).pdf

394-DVT prophylaxis-direct oral anticoagulant (DAO).pdf

395-DVT prophylaxis-direct oral anticoagulant (DAO).pdf

396-DVT prophylaxis-pentasaccharide.pdf

40-DVT prophylaxis-antithrombotics.pdf

400-atrial fibrillation-rate control.pdf

401-CABG surgery-radial graft.pdf

402-DVT prophylaxis-mechanical devices for thromboprophylaxis.pdf

403-cardiovascular prevention-antiplatelets drug.pdf

404-hypertension-anti hypertensive agent.pdf

404-hypertension-anti hypertensive agents.pdf

405-DVT prophylaxis-antithrombotics.pdf

406-DVT prophylaxis-antithrombotics.pdf

407-hypertension-antiplatelets drug.pdf

408-diabetes type 2-antidiabetic drugs added to metformin.pdf

409-diabetes type 2-insulin secretagogues.pdf

41-acute myocardial infarction-beta-blockers.pdf

410-post stroke-anti hypertensive agent.pdf

410-post stroke-anti hypertensive agents.pdf

411-post stroke-antiplatelets drug.pdf

413-post stroke-anticoagulant.pdf

414-diabetes type 2-anti hypertensive agent.pdf

414-diabetes type 2-anti hypertensive agents.pdf

415-diabetes type 2-anti hypertensive agent.pdf

415-diabetes type 2-anti hypertensive agents.pdf

416-diabetes type 2-prevention.pdf

418-cardiovascular prevention-polypill.pdf

419-abdominal aortic aneurysm-endovascular treatment.pdf

42-acute myocardial infarction-beta-blockers.pdf

420-abdominal aortic aneurysm-endovascular treatment.pdf

421-post stroke-prevention.pdf

422-coronary artery disease-Drug eluting stent.pdf

423-post acute coronary syndromes -antioxydants.pdf

424-post myocardial infarction-antioxydants.pdf

425-miscellaneous-angiotensin-receptor blockers.pdf

427-diabetes type 2-angiotensin-receptor blockers.pdf

428-acute coronary syndrome-oxygen therapy.pdf

429-acute myocardial infarction-oxygen therapy.pdf

43-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf

430-post stroke-foramen ovale closure .pdf

432-cardiovascular prevention-antioxydants.pdf

433-cardiovascular prevention-antioxydants.pdf

434-cardiovascular prevention-antioxydants.pdf

435-cardiovascular prevention-cholesterol lowering intervention.pdf

436-postthrombotic syndrome-prevention.pdf

437-cardiovascular prevention-antithrombotics.pdf

438-diabetes type 2-angiotensin renin system blockade.pdf

439-cardiac arrest-compression-only CPR.pdf

44-heart failure-beta-blockers.pdf

440-cardiovascular prevention-plasma homocysteine lowering intervention.pdf

441-cardiovascular prevention-plasma homocysteine lowering intervention.pdf

443-cardiovascular prevention-weight-loss drugs.pdf

444-cardiovascular prevention-weight-loss drugs.pdf

445-cardiovascular prevention-weight-loss drugs.pdf

446-diabetes type 2-weight-loss drugs.pdf

447-cardiovascular prevention-lifestyle intervention.pdf

448-cardiovascular prevention-lifestyle intervention.pdf

449-post myocardial infarction-secondary prevention.pdf

45-post myocardial infarction-cholesterol lowering intervention.pdf

450-coronary artery disease-death and events prevention.pdf

451-cardiovascular prevention-plasma homocysteine lowering intervention.pdf

452-cardiovascular prevention-hormonal replacement therapy.pdf

453-cardiovascular prevention-hormonal replacement therapy.pdf

454-cardiovascular prevention-hormonal replacement therapy.pdf

455-acute coronary syndrome-New P2Y12 Inhibitors.pdf

456-heart failure-HR-slowing agents.pdf

457-percutaneous coronary intervention-anticoagulant.pdf

458-hypertension-cholesterol lowering intervention.pdf

459-diabetes type 2-intensive therapy.pdf

46-heart failure-antiarrythmic drugs.pdf

460-heart failure-Miscellaneous.pdf

461-DVT prophylaxis-antiplatelets drug.pdf

462-DVT prophylaxis-antiplatelets drug.pdf

463-DVT prophylaxis-antiplatelets drug.pdf

464-DVT prophylaxis-antiplatelets drug.pdf

465-DVT prophylaxis-mechanical devices for thromboprophylaxis.pdf

466-DVT prophylaxis-mechanical devices for thromboprophylaxis.pdf

469-percutaneous coronary intervention-antithrombotics.pdf

47-Head and neck cancer-Induction chemotherapy.pdf

470-acute myocardial infarction-increasing hemoglobin concentration.pdf

471-heart failure-telemonitoring.pdf

472-heart failure-vasodilators therapy.pdf

475-DVT prophylaxis-direct oral anticoagulant (DAO).pdf

479-diabetes type 2-SGLT2 inhibitors.pdf

48-Head and neck cancer-Induction chemotherapy.pdf

480-acute coronary syndrome-direct oral anticoagulant (DAO).pdf

481-cardiovascular prevention-anticoagulant.pdf

482-aortic stenosis-transcatheter aortic-valve implantation (TAVI).pdf

483-diabetes type 2-insulin secretagogues - sulfonylureas.pdf

484-cardiac arrest-active compression-decompression CPR.pdf

485-DVT prophylaxis-direct oral anticoagulant (DAO).pdf

486-early breast cancer -monoclonal antibody.pdf

488-heart failure-aldosterone blockade .pdf

489-cardiac arrest-modified resuscitation protocol.pdf

49-peripheral vascular diseases-vasodilators therapy.pdf

490-diabetes type 2-insulin secretagogues peptides (incretins).pdf

495-hypertension-intensive blood pressure control.pdf

496-hypertension-angioplasty.pdf

5-cardiovascular prevention-cholesterol lowering intervention.pdf

50-peripheral vascular diseases-antithrombotics.pdf

501-stable angina-myocardial revascularization.pdf

502-coronary artery disease-myocardial revascularization.pdf

503-cardiovascular prevention-HDL increasing drugs.pdf

505-venous thrombosis-direct oral anticoagulant (DAO).pdf

509-diabetes type 2-antidiabetic drugs.pdf

51-peripheral vascular diseases-Exercise Therapy.pdf

510-diabetes type 2-antidiabetic drugs.pdf

511-diabetes type 2-antidiabetic drugs.pdf

512-diabetes type 2-antidiabetic drugs.pdf

513-diabetes type 2-antidiabetic drugs.pdf

514-atrial fibrillation-antiarrythmic drugs.pdf

515-heart failure-cell-based therapies .pdf

518-cardiovascular prevention-dietary salt reduction.pdf

519-cardiovascular prevention-dietary salt reduction.pdf

52-peripheral vascular diseases-cholesterol lowering intervention.pdf

520-cardiovascular prevention-dietary salt reduction.pdf

535-left ventricular dysfunction after myocardial infarction-All mechanism.pdf

544-diabetes type 2-antidiabetic drugs.pdf

545-diabetes type 2-antidiabetic drugs.pdf

546-diabetes type 2-antidiabetic drugs.pdf

547-diabetes type 2-antidiabetic drugs.pdf

548-diabetes type 2-insulin therapy.pdf

549-diabetes type 2-insulin secretagogues - Meglitinides (glinides).pdf

550-diabetes type 2-insulin secretagogues - DPP-4 inhibitors.pdf

551-diabetes type 2-insulin sensitizer - biguanides.pdf

552-diabetes type 2-insulin sensitizers - PPAR modulator.pdf

562-acute myocardial infarction-percutaneous left ventricular assist device .pdf

563-coronary artery disease-fractional-flow-reserve-guided PCI.pdf

564-acute coronary syndrome-antiplatelets drug.pdf

565-atrial fibrillation-antithrombotics.pdf

566-percutaneous coronary intervention-antiplatelets drug.pdf

568-cardiovascular prevention-diet.pdf

57-atrial fibrillation-antithrombotics.pdf

576-diabetes type 2-glucose lowering for cardiovascular prevention.pdf

578-stent-dual antiplatelet therapy .pdf

579-melanoma-All mechanism.pdf

580-melanoma-All mechanism.pdf

581-melanoma-All mechanism.pdf

582-lung cancer (metastatic)-immune checkpoint inhibition.pdf

582-lung cancer-immune checkpoint inhibition.pdf

583-multiple myeloma-All mechanism.pdf

584-multiple myeloma-All mechanism.pdf

587-advanced breast cancer (metastatic)-mTOR inhibitor .pdf

588-advanced breast cancer (metastatic)-Taxanes.pdf

589-advanced breast cancer (metastatic)-multi target TKI.pdf

590-advanced breast cancer (metastatic)-CDK (cyclin-dependent kinase) inhibitor.pdf

590-advanced breast cancer (metastatic)-cyclin inhibitors .pdf

591-advanced breast cancer (metastatic)-LHRH agonist.pdf

592-advanced breast cancer (metastatic)-aromatase inhibitors.pdf

594-advanced breast cancer (metastatic)- selective estrogen receptor modulator (SERM).pdf

595-advanced breast cancer (metastatic)-angiogenesis inhibitors.pdf

598-advanced breast cancer (metastatic)-monoclonal antibody.pdf

599-cardiovascular prevention-PCSK9 Inhibitors.pdf

6-cardiovascular prevention-cholesterol lowering intervention.pdf

601-advanced breast cancer (metastatic)-histone deacetylase (HDAC) inhibitors.pdf

602-advanced breast cancer (metastatic)-AKT Inhibitors.pdf

603-advanced breast cancer (metastatic)-Phosphoinositide 3-kinase inhibitor.pdf

604-advanced breast cancer (metastatic)-HER2 inhibitors.pdf

605-advanced breast cancer (metastatic)-nontaxane microtubule dynamics inhibitor .pdf

606-advanced breast cancer (metastatic)-Selective estrogen receptor downregulators (SERDs).pdf

607-advanced breast cancer (metastatic)-high dose chemotherapy.pdf

608-advanced breast cancer (metastatic)-combination chemotherapy with platinum salts.pdf

609-advanced breast cancer (metastatic)-Capecitabine containing-regimen.pdf

610-advanced breast cancer (metastatic)-Gemcitabine containg regimen.pdf

611-advanced breast cancer (metastatic)-Vinorelbine containing regimen.pdf

612-advanced breast cancer (metastatic)-maintenance chemotherapy.pdf

613-advanced breast cancer (metastatic)-ixabepilone based chemotherapy.pdf

614-advanced breast cancer (metastatic)-Anthracyclines based regimen.pdf

615-advanced breast cancer (metastatic)-Selective estrogen receptor downregulators (SERDs).pdf

616-advanced breast cancer (metastatic)-Selective estrogen receptor downregulators (SERDs).pdf

617-advanced breast cancer (metastatic)-mTOR inhibitor .pdf

618-advanced breast cancer (metastatic)-mTOR inhibitor .pdf

619-advanced breast cancer (metastatic)-mTOR inhibitor .pdf

62-acute coronary syndrome-antithrombotics.pdf

620-advanced breast cancer (metastatic)-angiogenesis inhibitors.pdf

621-advanced breast cancer (metastatic)-angiogenesis inhibitors.pdf

622-advanced breast cancer (metastatic)-locoregional treatment of the primary tumor.pdf

623-melanoma-Immunotherapy .pdf

624-lung cancer (metastatic)-angiogenesis inhibitors.pdf

624-lung cancer-angiogenesis inhibitors.pdf

625-lung cancer (metastatic)-EGFR inhibitors .pdf

625-lung cancer-EGFR inhibitors .pdf

627-lung cancer (metastatic)-Taxanes.pdf

627-lung cancer-Taxanes.pdf

628-advanced renal-cell carcinoma-multi target TKI.pdf

628-renal-cell carcinoma (advanced)-multi target TKI.pdf

629-advanced renal-cell carcinoma-Immunotherapy .pdf

629-renal-cell carcinoma (advanced)-Immunotherapy .pdf

63-percutaneous coronary intervention-antithrombotics.pdf

630-advanced renal-cell carcinoma-mTOR inhibitor .pdf

630-renal-cell carcinoma (advanced)-mTOR inhibitor .pdf

631-advanced renal-cell carcinoma-All mechanism.pdf

631-renal-cell carcinoma (advanced)-All mechanism.pdf

632-advanced renal-cell carcinoma-angiogenesis inhibitors.pdf

632-renal-cell carcinoma (advanced)-angiogenesis inhibitors.pdf

633-advanced renal-cell carcinoma-All mechanism.pdf

633-renal-cell carcinoma (advanced)-All mechanism.pdf

636-multiple myeloma-All mechanism.pdf

637-heart failure-combined inhibition of ACE and neprilysin.pdf

638-lung cancer (metastatic)-chemotherapy.pdf

638-lung cancer-chemotherapy.pdf

639-acute heart failure-diuretics.pdf

64-acute myocardial infarction-antithrombotics.pdf

640-acute heart failure-new drug under development.pdf

641-acute heart failure-vasodilators therapy.pdf

642-acute heart failure-vasopressin antagonist.pdf

643-acute heart failure-endothelin receptor antagonist .pdf

644-acute heart failure-atrial natriuretic peptide .pdf

645-acute heart failure-positive inotropic agent .pdf

646-acute heart failure-relaxin.pdf

647-acute heart failure-calcium sensitiser.pdf

648-acute heart failure-ultrafiltration.pdf

649-heart failure-regenerative therapy.pdf

65-heart failure-angiotensin-receptor blockers.pdf

650-lung cancer (metastatic)-immune checkpoint inhibition.pdf

650-lung cancer-immune checkpoint inhibition.pdf

652-acute coronary syndrome-antiplatelets drug.pdf

654-advanced breast cancer (metastatic)-AKT Inhibitors.pdf

655-advanced breast cancer (metastatic)-multi target TKI.pdf

656-advanced breast cancer (metastatic)-CDK (cyclin-dependent kinase) inhibitor.pdf

656-advanced breast cancer (metastatic)-cyclin inhibitors .pdf

657-advanced breast cancer (metastatic)-histone deacetylase (HDAC) inhibitors.pdf

658-advanced breast cancer (metastatic)-mTOR inhibitor .pdf

659-advanced breast cancer (metastatic)-Phosphoinositide 3-kinase inhibitor.pdf

66-heart failure-angiotensin-receptor blockers.pdf

660-advanced breast cancer (metastatic)-HER2 inhibitors.pdf

661-peripheral vascular diseases-antithrombotics.pdf

662-peripheral vascular diseases-anticoagulant.pdf

663-cardiovascular prevention-antithrombotics.pdf

664-heart failure-Miscellaneous.pdf

665-heart failure-mineralocorticoid receptor antagonists .pdf

666-heart failure-mineralocorticoid receptor antagonists .pdf

667-diabetic kidney disease-All mechanism.pdf

668-percutaneous coronary intervention-bioresorbable vascular scaffold.pdf

669-lung cancer (metastatic)-ALK inhibitors.pdf

669-lung cancer-ALK inhibitors.pdf

67-heart failure-angiotensin-receptor blockers.pdf

670-advanced breast cancer (metastatic)-immune checkpoint inhibition.pdf

671-advanced breast cancer (metastatic)-FGFR inhibitors.pdf

672-advanced breast cancer (metastatic)-FGFR inhibitors.pdf

673-coronary artery disease-anticoagulant.pdf

675-advanced urothelial carcinoma-immune checkpoint inhibition.pdf

675-urothelial carcinoma (advanced)-immune checkpoint inhibition.pdf

676-advanced breast cancer (metastatic)-poly ADP-ribose polymerase (PARP) inhibitor.pdf

677-advanced breast cancer (metastatic)-poly ADP-ribose polymerase (PARP) inhibitor.pdf

678-early breast cancer -HER2 inhibitors.pdf

679-sarcoma-Miscellaneous.pdf

68-heart failure-angiotensin-receptor blockers.pdf

680-advanced breast cancer (metastatic)-poly ADP-ribose polymerase (PARP) inhibitor.pdf

681-ovarian cancer-poly ADP-ribose polymerase (PARP) inhibitor.pdf

682-venous thrombosis-antithrombotics.pdf

683-post acute coronary syndromes -anti inflammatory drugs.pdf

684-post myocardial infarction-anti inflammatory drugs.pdf

685-hypertension-anti hypertensive agents.pdf

686-hypertension-anti hypertensive agents.pdf

687-hypertension-anti hypertensive agents.pdf

688-cardiovascular prevention-statins.pdf

689-cardiovascular prevention-statins.pdf

690-Head and neck cancer-immune checkpoint inhibition.pdf

691-multiple myeloma-immune checkpoint inhibition.pdf

692-diabetes type 2-glucose lowering for cardiovascular prevention.pdf

693-hypertension-renal denervation.pdf

694-cardiovascular prevention-statins.pdf

695-cardiovascular prevention-statins.pdf

696-heart failure-statins.pdf

698-lung cancer (metastatic)-EGFR inhibitors .pdf

699-lung cancer (metastatic)-EGFR inhibitors .pdf

7-cardiovascular prevention-cholesterol lowering intervention.pdf

70-heart failure-calcium channel blockers.pdf

700-lung cancer (metastatic)-immune checkpoint inhibition.pdf

701-lung cancer (metastatic)-immune checkpoint inhibition.pdf

702-ovarian cancer-poly ADP-ribose polymerase (PARP) inhibitor.pdf

703-ovarian cancer-poly ADP-ribose polymerase (PARP) inhibitor.pdf

706-cardiovascular prevention-direct oral anticoagulant (DAO).pdf

707-cardiovascular prevention-direct factor Xa inhibitors.pdf

708-cardiovascular prevention-antiplatelets drug.pdf

709-cardiovascular prevention-anticoagulant.pdf

71-heart failure-angiotensin-Converting Enzyme Inhibitors.pdf

710-cardiovascular prevention-anticoagulant.pdf

711-advanced renal-cell carcinoma-immune checkpoint inhibition.pdf

711-renal-cell carcinoma (advanced)-immune checkpoint inhibition.pdf

712-melanoma-immune checkpoint inhibition.pdf

713-lung cancer (metastatic)-CDK (cyclin-dependent kinase) inhibitor.pdf

714-melanoma-immune checkpoint inhibition.pdf

715-melanoma-immune checkpoint inhibition.pdf

716-melanoma-immune checkpoint inhibition.pdf

717-melanoma-chemotherapy.pdf

718-melanoma-B-Raf enzyme inhibitors.pdf

72-heart failure-antithrombotics.pdf

73-heart failure-antithrombotics.pdf

74-heart failure-diuretics.pdf

75-heart failure-diuretics.pdf

76-heart failure-diuretics.pdf

77-heart failure-cholesterol lowering intervention.pdf

78-heart failure-digitalis glycosides.pdf

79-heart failure-vasodilators therapy.pdf

80-diabetes type 2-antidiabetic drugs.pdf

81-diabetes type 2-antidiabetic drugs.pdf

82-diabetes type 2-antidiabetic drugs.pdf

83-diabetes type 2-anti hypertensive agent.pdf

83-diabetes type 2-anti hypertensive agents.pdf

85-diabetes type 2-cholesterol lowering intervention.pdf

87-DVT prophylaxis-antithrombotics.pdf

88-heart failure-Exercise Therapy.pdf

89-CABG surgery-cholesterol lowering intervention.pdf

9-hypertension-anti hypertensive agent.pdf

9-hypertension-anti hypertensive agents.pdf

90-acute myocardial infarction-myocardial revascularization.pdf

92-DVT prophylaxis-antithrombotics.pdf

93-DVT prophylaxis-antithrombotics.pdf

94-DVT prophylaxis-antithrombotics.pdf

95-DVT prophylaxis-antithrombotics.pdf

96-DVT prophylaxis-antithrombotics.pdf

97-patients at high risk for cardiovascular events-angiotensin-receptor blockers.pdf

98-patients at high risk for cardiovascular events-angiotensin-Converting Enzyme Inhibitors.pdf

99-DVT prophylaxis-antithrombotics.pdf